BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1325530)

  • 21. Heparin enhances endothelial cell von Willebrand factor content by growth factor dependent mechanisms.
    Tannenbaum SH; Chao ES; Gralnick HR
    Thromb Haemost; 1994 Nov; 72(5):770-6. PubMed ID: 7900084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells.
    Kohlstedt K; Brandes RP; Müller-Esterl W; Busse R; Fleming I
    Circ Res; 2004 Jan; 94(1):60-7. PubMed ID: 14615289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A
    Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are Angiotensin Converting Enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease?
    Falcini F; Generini S; Pignone A; Leoncini G; Cimaz R; Partsch G; Matucci-Cerinic M
    Endothelium; 1999; 6(3):209-15. PubMed ID: 10365772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise induced release of von Willebrand factor: evidence for hypoxic reperfusion microvascular injury in rheumatoid arthritis.
    Farrell AJ; Williams RB; Stevens CR; Lawrie AS; Cox NL; Blake DR
    Ann Rheum Dis; 1992 Oct; 51(10):1117-22. PubMed ID: 1444624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical correlations of plasma angiotensin converting enzyme (ACE) activity in systemic sclerosis: a longitudinal study of plasma ACE level, endothelial injury and lung involvement.
    Matucci-Cerinic M; Pignone A; Iannone F; Lotti T; Pesciullesi E; Spillantini G; Falcini F; Cagnoni M
    Respir Med; 1990 Jul; 84(4):283-7. PubMed ID: 2173047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo expression of endothelial von Willebrand factor and leukocyte accumulation after fractionated irradiation.
    van Kleef E; Verheij M; te Poele H; Oussoren Y; Dewit L; Stewart F
    Radiat Res; 2000 Oct; 154(4):375-81. PubMed ID: 11023600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of endothelial cell synthesis of von Willebrand factor by mononuclear cell products.
    Breit SN; Green I
    Haemostasis; 1988; 18(3):137-45. PubMed ID: 3263302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro: morphological and biochemical evidence.
    Roberts JM; Edep ME; Goldfien A; Taylor RN
    Am J Reprod Immunol; 1992; 27(3-4):101-8. PubMed ID: 1418401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paraquat depresses the activity of angiotensin converting enzyme expressed by human umbilical vein endothelial cells in culture.
    Watanabe K; Tamaru N; Yoshida M
    Cell Biol Int Rep; 1991 Mar; 15(3):205-10. PubMed ID: 1851671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of enzymatic treatments on the storage and secretion of von Willebrand factor by human endothelial cells.
    Lopes AA; Peranovich TM; Maeda NY; Bydlowski SP
    Thromb Res; 2001 Feb; 101(4):291-7. PubMed ID: 11248290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced release of von Willebrand factor by human endothelial cells in culture in the presence of phorbol myristate acetate and interleukin 1.
    Giddings JC; Shall L
    Thromb Res; 1987 Aug; 47(3):259-67. PubMed ID: 3307015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early effects of ionizing radiation on pulmonary endothelial angiotensin-converting enzyme and 5'-nucleotidase, in vivo.
    Catravas JD; Burch SE; Spurlock BO; Mills LR
    Toxicol Appl Pharmacol; 1988 Jul; 94(3):342-55. PubMed ID: 2840753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased plasma von Willebrand factor in the systemic inflammatory response syndrome is derived from generalized endothelial cell activation.
    McGill SN; Ahmed NA; Christou NV
    Crit Care Med; 1998 Feb; 26(2):296-300. PubMed ID: 9468168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial microparticles induce vascular endothelial cell injury in children with Kawasaki disease.
    Tian J; Lv HT; An XJ; Ling N; Xu F
    Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1814-8. PubMed ID: 27212174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial cell injury partly induced by mesenteric lymph in heat stroke.
    Tong H; Wan P; Zhang X; Duan P; Tang Y; Chen Y; Tang L; Su L
    Inflammation; 2014 Feb; 37(1):27-34. PubMed ID: 23912649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular origin determines angiotensin I-converting enzyme expression in endothelial cells.
    Baudin B; Berard M; Carrier JL; Legrand Y; Drouet L
    Endothelium; 1997; 5(1):73-84. PubMed ID: 9142323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of tumour necrosis factor and interleukin-1 on von Willebrand factor secretion from human vascular endothelial cells.
    Paleolog EM; Carew MA; Pearson JD
    Int J Radiat Biol; 1991; 60(1-2):279-85. PubMed ID: 1677983
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of ginsenoside Rgl on the release of enzymes by cultured endothelial cells.
    Ushio Y
    Am J Chin Med; 1992; 20(1):91-101. PubMed ID: 1318638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.